3 Risks to Consider Before Investing in Teladoc
Teladoc Health (NYSE: TDOC) has established itself as a well-known player in the virtual medicine space over the past couple of years. The pandemic caused Teladoc shares to skyrocket nearly 140% in 2020 as stay-at-home orders kept patients from seeing their doctors in person. In 2021, many of these restrictions were lifted, leading people to return to in-person activities. As a result, Teladoc shares are down 75% in the past year.
The Global Telemedicine Market is set to grow at a compound annual growth rate of 26% up to $432 billion by 2030, according to a report published by Allied Market Research. Teladoc's addressable market is massive, but short-term headwinds have caused investors to unload shares of the company's stock. While I believe Teladoc has a very promising future ahead, there are three key risks investors should consider.
Image source: Getty Images
Source Fool.com
